New strategies for the treatment of neurotoxic side effects in CAR-T cell therapy / 中国肿瘤生物治疗杂志
Chinese Journal of Cancer Biotherapy
; (6): 617-622, 2019.
Article
em Zh
| WPRIM
| ID: wpr-798307
Biblioteca responsável:
WPRO
ABSTRACT
@# Chimeric antigen receptor modified T (CAR-T) cell therapy is one of the important methods of tumor immunotherapy. The targeting, killing, proliferation and persistence of CAR-T cells are significantly enhanced than that of conventional T cells.After continuous improvement and evolution, CAR-T cell treatment has achieved excellent progress in hematological tumors and has received extensive attention. However, neurotoxicity arising from the treatment, also known as CAR-T cell relevant encephalopathy syndrome (CRES), has affected its clinical application. Exploring the pathogenesis of CRES and high-risk factors, and finding appropriate strategies is therefore critical for the prevention and treatment of CRES. Here, we take CD19-CAR-T cell treatment as example to review the symptoms and pathogenesis of CRES, discuss high-risk factors as well as coping strategies, in an effort to provide a reference for clinical treatment.
Texto completo:
1
Base de dados:
WPRIM
Tipo de estudo:
Risk_factors_studies
Idioma:
Zh
Revista:
Chinese Journal of Cancer Biotherapy
Ano de publicação:
2019
Tipo de documento:
Article